Viewing Study NCT02598427


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-02-26 @ 6:28 AM
Study NCT ID: NCT02598427
Status: TERMINATED
Last Update Posted: 2018-02-28
First Post: 2015-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer
Sponsor: Kimberly Blackwell
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module